Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions

Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions

10.3390/vaccines11061020

Saved in:

Bibliographic Details
Main Authors:	Lim, Xin Rong, Chan, Grace Yin Lai, Tan, Justina Wei Lynn, Ng, Carol Yee Leng, Chua, Choon Guan, Tan, Guat Bee, Chan, Stephrene Seok Wei, Ong, Kiat Hoe, Tan, Ying Zhi, Tan, Sarah Hui Zhen, Teo, Claire Min Li, Lee, Samuel Shang Ming, Thong, Bernard Yu Hor, Leung, Bernard Pui Lam
Other Authors:	MEDICINE
Format:	Article
Published:	MDPI AG 2023
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/241137
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
by: Lim, Xin Rong, et al.
Published: (2021)

Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)
by: Lin, Weiqin, et al.
Published: (2022)

Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing
by: Siripipattanamongkol N.
Published: (2023)

Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
by: Tan, Sharon H. X., et al.
Published: (2023)

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
by: Rebecca P. Payne, et al.
Published: (2022)

Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
by: Mansanguan S.
Published: (2023)

Immediate type hypersensitivity to chemotherapeutic agents in pediatric patients
by: Nualanong Visitsunthorn, et al.
Published: (2018)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
by: Wang, Bei, et al.
Published: (2022)

Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees
by: Low, Jia Ming, et al.
Published: (2021)

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
by: Pimchanok Kulsirichawaroj, et al.
Published: (2022)

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
by: Kulsirichawaroj P.
Published: (2023)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023)

Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients
by: Tan, Eunice X, et al.
Published: (2023)

Clinical course, immunogenicity, and efficacy of BNT162b2 mRNA vaccination against SARS-CoV-2 infection in liver transplant recipients
by: Tan, Eunice X., et al.
Published: (2024)

Basophil activation test in diagnosis of immediate iodinated contrast media hypersensitivity patients
by: Panwas Pinnobphun
Published: (2013)

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
by: Napaporn Chantasrisawad, et al.
Published: (2022)

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
by: Chantasrisawad N.
Published: (2023)

BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study
by: Lim, Xin Rong, et al.
Published: (2023)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
by: Renia, Laurent, et al.
Published: (2023)

Human Milk Antibodies Elicited by BNT162b2 Vaccination have reduced activity against SARS-CoV-2 Variants of Concern
by: Low, Jia Ming, et al.
Published: (2023)

Human Milk Antibodies after BNT162b2 Vaccination Exhibit Reduced Binding against SARS-CoV-2 Variants of Concern
by: Low, Jia Ming, et al.
Published: (2023)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
by: Renia, Laurent, et al.
Published: (2022)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
by: Suvimol Niyomnaitham, et al.
Published: (2022)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
by: Niyomnaitham S.
Published: (2023)

Anaphylatoxin signaling in human neutrophils: A key role for sphingosine kinase
by: Ibrahim, F.B.M., et al.
Published: (2011)

Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
by: Chia, Wan Ni, et al.
Published: (2023)

BNT162b2 vaccination induces SARS-CoV-2 specific antibody secretion into human milk with minimal transfer of vaccine mRNA
by: Low, Jia Ming, et al.
Published: (2023)

BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study.
by: Yung, Chee Fu, et al.
Published: (2023)

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study
by: Yung, Chee Fu, et al.
Published: (2024)

Basophil activation test in immediate-type hypersensitivity reactions to betalactams using CD63 and CCR3 in Thailand
by: Pongtong Puranitee, et al.
Published: (2019)

Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication
by: Bernard Yu-Hor Thong, et al.
Published: (2022)

Studies on the intracellular signalling pathways triggered by the anaphylatoxin C5a in human phagocytic cells
by: FARAZEELA BINTE MOHD IBRAHIM
Published: (2010)

A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo
by: Vlasenko, L.P., et al.
Published: (2011)

Robust sars?cov?2 antibody responses in asian covid?naïve subjects 180 days after two doses of bnt162b2 mrna covid?19 vaccine
by: Lau, Chin-Shern, et al.
Published: (2022)

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial
by: Chantasrisawad N.
Published: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Safety and immunogenicity of intradermal administration of fractional dose CoronaVac<sup>®</sup>, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
by: Chatsiricharoenkul S.
Published: (2023)

Report on industrial attachment with Pfizer Nutrition Singapore Pte Ltd
by: Tay, Grace Sin Yee
Published: (2014)

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
by: Niyomnaitham S.
Published: (2023)